Almirall SA 2020 AR2
The report highlights Almirall's financial and ESG performance for the fiscal year 2020, during which the company joined the IBEX 35 index. Despite pandemic-related challenges, Almirall treated over 6.3 million dermatology patients and invested approximately 10% of its net sales into research and development. In terms of environmental action, the company achieved a 34% reduction in greenhouse gas emissions compared to 2014 and earned an A- score from the CDP. On the social front, Almirall launched a COVID-19 action plan, donating over 100,000 health products and supporting healthcare professionals.
Company: Almirall SA
Sector: Manufacturing
Country: Spain
Year: 2020
Type: AR2
Pages: 55
Back to company
Almirall SA
Annual Report
The report highlights Almirall's financial and ESG performance for the fiscal year 2020, during which the company joined the IBEX 35 index. Despite pandemic-related challenges, Almirall treated over 6.3 million dermatology patients and invested approximately 10% of its net sales into research and development. In terms of environmental action, the company achieved a 34% reduction in greenhouse gas emissions compared to 2014 and earned an A- score from the CDP. On the social front, Almirall launched a COVID-19 action plan, donating over 100,000 health products and supporting healthcare professionals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Renewable Energy
Total Waste
Employees